Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Technology, Cell Type); Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopedic, Others); End user (Hospitals and Clinics, Diagnostic Centers, Regenerative Medicine Centers, Academic and Research Institute)

Publication Month: Apr 2021 | Report Code: TIPRE00021550 | No. of Pages: 221 | Category: Biotechnology | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The cell therapy bioprocessing is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028.

 

The cell therapy bioprocessing market has been analyzed on the basis of technology, cell type, end user, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the cell therapy bioprocessing market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.

 

Lucrative Regions for Cell Therapy Bioprocessing Market

Lucrative Regions for Cell Therapy Bioprocessing Market

Get more information on this report :


 

Market Insights


Growing Approvals for Cell Therapies

Cell therapies have shown positive results in treating various chronic diseases including rare genetic disorders by offering regenerative medicines and personalized medicines. Increasing need of treating chronic diseases have pushed the research and development activities resulting in growing cell therapy production and product approvals. Few instances are listed below for the cell therapies approvals that have contributed to the growth of the cell therapy bioprocessing market.

  • In May 2019, the Food and Drug Administration (FDA) approved Zolgensma, manufactured by AveXis, Inc. A subsidiary of Novartis AG. Zolgensa is designed to treat spinal muscular atrophy in children below two years and is given by infusing one-time into the vein.
  • In July 2020, Kite Pharma, Inc., a Subsidiary of Gilead Company, received FDA approval for its Tecartus. Tecartus is (CAR) T cell therapy designed to treat refractory mantle cell lymphoma (MCL) in adults. According to toe Gilead Company, Tecartus is the first approved (CAR) T cell therapy for mantle cell lymphoma, which is expected to be a new frontier in the treatment of mantle cell lymphoma.
  • In February 2021, Juno Therapeutics, Inc., a subsidiary of Bristol-Myers Squibb Company, received approval for its Breyanzi. Breyanzi is a cell-based gene therapy intended to treat certain types of large B-cell lymphoma in adults. The treatment is given after patient have not responded to minimum two other types of systemic treatment. However, Breyanzi in 2019, faced regulatory setback since its first filing; it is currently under the European Medicines Agency’s review and was validated in July 2020.

Thus, growing product developments have resulted in various product approvals that reflects the increase in cell therapies. Therefore, it is expected that the growing approvals for cell therapies are enormously increasing the cell therapy bioprocessing, which, in turn is likely to drive the market’s growth over the coming years

 

Technology-Based Insights

The cell therapy bioprocessing market, by technology, is segmented into bioreactor, lyophilization, electro spinning, controlflow centrifugation, ultrasonic lysis, genome editing technology, cell immortalization technology, and viral vector technology. The Bioreactor segment held the largest share of the market in 2020, whereas the genome editing technology segment is anticipated to register the highest CAGR of 14.5% in the market during the forecast period.

 

Cell Therapy Bioprocessing Market, by Technology– 2020 and 2028

Cell Therapy Bioprocessing Market, by Technology– 2020 and 2028

Get more information on this report :


 

Cell Type-Based Insights

The cell therapy bioprocessing market, by cell type, is segmented into stem cell, immune cell, human embryonic stem cell, pluripotent stem cell, hematopoietic stem cells. The stem cell segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 14.0% in the market during the forecast period.

 

End User-Based Insights

The cell therapy bioprocessing market, by indication, is segmented cardiovascular disease (CVD), oncology, wound healing, orthopedic, and others. The oncology segment held the largest share of the market in 2020, and the orthopedic segment is anticipated to register the highest CAGR of 14.3% in the market during the forecast period.


Strategic Insights

Companies operating in the cell therapy bioprocessing market are adopting organic strategies such as product launches and expansions to expand their footprint and product portfolio worldwide as well as to address the growing demands.

 

By Technology

  • Bioreactor
  • Lyophilization
  • Electrospinning
  • Controlflow Centrifugation
  • Ultrasonic Lysis
  • Genome Editing Technology
  • Cell Immortalization Technology
  • Viral Vector Technology

By Cell Type

  • Stem Cell
  • Immune Cell
  • Human Embryonic Stem Cell
  • Pluripotent Stem Cell
  • Hematopoetic Stem Cell

By Indication

  • Cardiovascular Disease (CVD)
  • Oncology
  • Wound Healing
  • Orthopedic
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Regenerative Medicine Centers
  • Academic and Research Institute

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • Fresenius Kabi AG                                     
  • Asahi Kasei Corporation                          
  • Sartorius AG                                               
  • MERCK KGaA                                             
  • THERMO FISHER SCIENTIFIC INC.           
  • Corning Incorporated                                
  • Cytiva                                                           
  • Lonza                                                           
  • Repligen                                                      
  • Catalent Inc

1.            Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Cell Therapy Bioprocessing Market – By Technology

1.3.2        Cell Therapy Bioprocessing Market – By Cell Type

1.3.3        Cell Therapy Bioprocessing Market – By Indication

1.3.4        Cell Therapy Bioprocessing Market – By End User

1.3.5        Cell Therapy Bioprocessing Market– By Geography

2.            Cell Therapy Bioprocessing Market– Key Takeaways

3.            Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.            Cell Therapy Bioprocessing Market– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East and Africa PEST Analysis

4.2.5        South and Central America PEST Analysis

4.3       Expert Opinion

5.            Cell Therapy Bioprocessing Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Increasing Investments for Cell and Gene Therapy Manufacturing

5.1.2        Growing Approvals for Cell Therapies

5.2       Market Restraints

5.2.1        Challenges Associated with Cell Therapy Bioprocessing

5.3       Market Opportunities

5.3.1        Automated Procedures to Produce Cell Therapies

5.4       Future Trends

5.4.1        Digital Biomanufacturing

5.5       Impact Analysis

6.            Cell Therapy Bioprocessing Market– Global Analysis

6.1       Global Cell Therapy Bioprocessing Market Revenue Forecast and Analysis

6.2       Global Cell Therapy Bioprocessing Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.            Cell Therapy Bioprocessing Market Analysis – By Technology

7.1       Overview

7.2       Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

7.3       Bioreactor

7.3.1        Overview

7.3.2        Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.4       Lyophilization

7.4.1        Overview

7.4.2        Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.5       Electrospinning

7.5.1        Overview

7.5.2        Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.6       Controlflow Centrifugation

7.6.1        Overview

7.6.2        Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

7.7       Ultrasonic Lysis

7.7.1        Overview

7.7.2        Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.8       Genome Editing Technology

7.8.1.1      Overview

7.8.2        Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

7.9       Cell Immortalization Technology

7.9.1        Overview

7.9.2        Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.10    Viral Vector Technology

7.10.1.1   Overview

7.10.2     Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.            Cell Therapy Bioprocessing Market Analysis – By Cell Type

8.1       Overview

8.2       Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

8.3       Stem Cell

8.3.1        Overview

8.3.2        Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.4       Immune Cell

8.4.1        Overview

8.4.2        Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.5       Human Embryonic Stem Cell

8.5.1        Overview

8.5.2        Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

8.6       Pluripotent Stem Cell

8.6.1        Overview

8.6.2        Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.7       Hematopoietic Stem Cell

8.7.1        Overview

8.7.2        Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

9.            Cell Therapy Bioprocessing Market Analysis – By Indication

9.1       Overview

9.2       Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

9.3       Cardiovascular Disease (CVD)

9.3.1        Overview

9.3.2        Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028  (US$ Million)

9.4       Oncology

9.4.1        Overview

9.4.2        Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.5       Wound Healing

9.5.1        Overview

9.5.2        Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.6       Orthopedic

9.6.1        Overview

9.6.2        Orthopedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.7       Others

9.7.1        Overview

9.7.2        Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.         Cell Therapy Bioprocessing Market– By End User

10.1    Overview

10.2    Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

10.3    Hospitals and Clinics

10.3.1     Overview

10.3.2     Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.4    Diagnostic Centres

10.4.1     Overview

10.4.2     Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.5    Regenerative Medicine Centres

10.5.1     Overview

10.5.2     Regenerative Medicine Centers: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.6    Academic and Research Institute

10.6.1     Overview

10.6.2     Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

11.         Cell Therapy Bioprocessing Market – Geographical Analysis

11.1    North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.1.1     Overview

11.1.2     North America: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3     North America: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.4     North America: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.5     North America: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.6     North America: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.7     North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.1.8     US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1   US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2   US: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.8.3   US: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.8.4   US: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.8.5   US: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.9     Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1   Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.2   Canada: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.9.3   Canada: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.9.4   Canada: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.9.5   Canada: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.10   Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1 Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.2 Mexico: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.10.3 Mexico: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.10.4 Mexico: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.10.5 Mexico: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2    Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.2.1     Overview

11.2.2     Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.3     Europe: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.4     Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.5     Europe: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.6     Europe: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.7     Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.2.8     Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1   Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.2   Germany: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.8.3   Germany: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.8.4   Germany: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.8.5   Germany: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.9     UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.1   UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.2   UK: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.9.3   UK: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.9.4   UK: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.9.5   UK: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.10   France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.1 France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.2 France: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.10.3 France: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.10.4 France: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.10.5 France: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.11   Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.1 Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.2 Spain: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.11.3 Spain: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.11.4 Spain: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.11.5 Spain: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.12   Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.1 Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.2 Italy: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.12.3 Italy: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.12.4 Italy: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.12.5 Italy: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.2.13   Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.1 Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.2 Rest of Europe: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.2.13.3 Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.2.13.4 Rest of Europe: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.2.13.5 Rest of Europe: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3    Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.3.1     Overview

11.3.2     Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.3     Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.4     Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.5     Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.6     Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.7     Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.3.8     China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1   China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2   China: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.8.3   China: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.8.4   China: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.8.5   China: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.9     Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.1   Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.2   Japan: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.9.3   Japan: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.9.4   Japan: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.9.5   Japan: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.10   India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.1 India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.2 India: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.10.3 India: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.10.4 India: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.10.5 India: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.11   South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.1 South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.2 South Korea: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.11.3 South Korea: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.11.4 South Korea: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.11.5 South Korea: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.12   Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.1 Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.2 Australia: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.12.3 Australia: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.12.4 Australia: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.12.5 Australia: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.3.13   Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.1 Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.2 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.3.13.3 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.3.13.4 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.3.13.5 Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4    Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.4.1     Overview

11.4.2     Middle East & Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.3     Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.4     Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.5     Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.6     Middle East & Africa: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.7     Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.4.8     UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.1   UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.2   UAE: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.8.3   UAE: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.8.4   UAE: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.8.5   UAE: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.9     Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.9.1   Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.9.2   Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.9.3   Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.9.4   Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.9.5   Saudi Arabia: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.10   South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.10.1 South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.10.2 South Africa: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.10.3 South Africa: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.10.4 South Africa: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.10.5 South Africa: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.4.11   Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.11.1 Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.4.11.2 Rest of MEA: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.4.11.3 Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.4.11.4 Rest of MEA: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.4.11.5 Rest of MEA: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5    South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.5.1     Overview

11.5.2     South and Central America: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028  (USD Million)

11.5.3     South and Central America: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.4     South and Central America: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.5     South and Central America: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.6     South and Central America: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.7     South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.5.8     Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.1   Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.2   Brazil: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.8.3   Brazil: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.8.4   Brazil: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.8.5   Brazil: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.9     Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.1   Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.2   Argentina: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.9.3   Argentina: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.9.4   Argentina: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.9.5   Argentina: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.5.10   Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.1 Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.2 Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.5.10.3 Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.5.10.4 Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.5.10.5 Rest of SCAM: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

12.         Impact Of COVID-19 Pandemic on Global Cell Therapy Bioprocessing Market

12.1    North America: Impact Assessment of COVID-19 Pandemic

12.2    Europe: Impact Assessment of COVID-19 Pandemic

12.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4    Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12.5    South & Central America: Impact Assessment of COVID-19 Pandemic

13.         Cell Therapy Bioprocessing Market–Industry Landscape

13.2    Growth Strategies Done by the Companies in the Market, (%)

13.3    Organic Developments

13.3.1     Overview

13.4    Inorganic Developments

13.4.1     Overview

14.         Company Profiles

14.1    Fresenius Kabi AG

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    Asahi Kasei Corporation

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    Sartorius AG

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    MERCK KGaA

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    THERMO FISHER SCIENTIFIC INC.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    Corning Incorporated

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    Cytiva

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    Lonza

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Repligen

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10 Catalent Inc

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.         Appendix

15.1    About the Insight Partners

15.2    Glossary of Terms

LIST OF TABLES

Table 1.            North America: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028  (USD Million)

Table 2.            North America: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 3.            North America: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4.            North America: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.            US: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6.            US: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 7.            US: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 8.            US: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.            Canada: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 12.          Canada: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Mexico: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Europe: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 18.          Europe: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          Europe: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 20.          Europe: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Germany: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 22.          Germany: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Germany: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 24.          Germany: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.          UK: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 26.          UK: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 27.          UK: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 28.          UK: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 29.          France: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 30.          France: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 31.          France: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 32.          France: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 33.          Spain: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 34.          Spain: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 35.          Spain: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 36.          Spain: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 37.          Italy: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 38.          Italy: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 39.          Italy: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 40.          Italy: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 41.          Rest of Europe: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028  (USD Million)

Table 42.          Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 43.          Rest of Europe: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028  (USD Million)

Table 44.          Rest of Europe: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 45.          Asia Pacific: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 46.          Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 47.          Asia Pacific: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 48.          Asia Pacific: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 49.          China: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 50.          China: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 51.          China: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 52.          China: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 53.          Japan: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 54.          Japan: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 55.          Japan: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 56.          Japan: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 57.          India: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 58.          India: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 59.          India: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 60.          India: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 61.          South Korea: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 62.          South Korea: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 63.          South Korea: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 64.          South Korea: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 65.          Australia: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 66.          Australia: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 67.          Australia: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 68.          Australia: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 69.          Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 70.          Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 71.          Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028  (USD Million)

Table 72.          Rest of Asia Pacific: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028  (USD Million)

Table 73.          Middle East & Africa: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028  (USD Million)

Table 74.          Middle East & Africa: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 75.          Middle East & Africa: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028  (USD Million)

Table 76.          Middle East & Africa: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 77.          UAE: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 78.          UAE: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 79.          UAE: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 80.          UAE: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 81.          Saudi Arabia: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 82.          Saudi Arabia: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 83.          Saudi Arabia: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 84.          Saudi Arabia: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 85.          South Africa: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 86.          South Africa: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 87.          South Africa: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 88.          South Africa: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 89.          Rest of MEA: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 90.          Rest of MEA: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 91.          Rest of MEA: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 92.          Rest of MEA: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 93.          South and Central America: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 94.          South and Central America: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 95.          South and Central America: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 96.          South and Central America: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 97.          Brazil: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 98.          Brazil: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 99.          Brazil: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 100.       Brazil: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 101.       Argentina: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 102.       Argentina: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 103.       Argentina: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 104.       Argentina: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 105.       Rest of SCAM: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028  (USD Million)

Table 106.       Rest of SCAM: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 107.       Rest of SCAM: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 108.       Rest of SCAM: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 109.       Organic Developments Done By Companies

Table 110.       Inorganic Developments Done By Companies

Table 111.       Glossary of Terms, Cell Therapy Bioprocessing Market

 

LIST OF FIGURES

Figure 1.           Cell Therapy Bioprocessing Market Segmentation

Figure 2.           Cell Therapy Bioprocessing Segmentation, By Region

Figure 3.           Global Cell Therapy Bioprocessing Market Overview

Figure 4.           Bioreactor Held Largest Share of Technology Segment in Cell Therapy Bioprocessing Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Cell Therapy Bioprocessing Market, by Geography (US$ Million)

Figure 7.           Global Cell Therapy Bioprocessing Market– Leading Country Markets (US$ Million)

Figure 8.           Global Cell Therapy Bioprocessing Market, Industry Landscape

Figure 9.           North America: PEST Analysis

Figure 10.        Europe: PEST Analysis

Figure 11.        Asia Pacific: PEST Analysis

Figure 12.        Middle East and Africa: PEST Analysis

Figure 13.        South and Central America: PEST Analysis

Figure 14.        Expert Opinion

Figure 15.        Cell Therapy Bioprocessing Market Impact Analysis of Drivers and Restraints

Figure 16.        Global Cell Therapy Bioprocessing Market– Revenue Forecast and Analysis – 2020- 2028

Figure 17.        Global Cell Therapy Bioprocessing Market– By Geography Forecast and Analysis – 2020- 2028

Figure 18.        Market Positioning of Key Players in Global Cell Therapy Bioprocessing Market

Figure 19.        Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

Figure 20.        Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

Figure 29.        Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

Figure 35.        Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Orthopedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        8.2 Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

Figure 41.        Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Regenerative Medicine Centers: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45.        North America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 46.        North America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 47.        North America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 48.        US: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Canada: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Mexico: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Europe: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 52.        Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 53.        Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 54.        Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 55.        UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 57.        Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 58.        Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 59.        Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 60.        Asia Pacific: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 61.        Asia Pacific: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 62.        Asia Pacific: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 63.        China: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 64.        Japan: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 65.        India: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 66.        South Korea: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 67.        Australia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 68.        Rest of Asia Pacific: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 69.        Middle East & Africa: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 70.        Middle East & Africa: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 71.        Middle East & Africa: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 72.        UAE: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 73.        Saudi Arabia: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 74.        South Africa: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 75.        Rest of MEA: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 76.        South and Central America: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 77.        South and Central America: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028 (USD Million)

Figure 78.        South and Central America: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 79.        Brazil: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 80.        Argentina: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 81.        Rest of SCAM: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 82.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 83.        Impact of COVID-19 Pandemic in European Country Markets

Figure 84.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 85.        Impact of COVID-19 Pandemic in Middle East & Africa Market

Figure 86.        Impact of COVID-19 Pandemic in South & Central America Market

Figure 87.        Growth Strategies Done by the Companies in the Market, (%)

 


The List of Companies - Cell Therapy Bioprocessing Market

  1. Fresenius Kabi AG     
  2. Asahi Kasei Corporation         
  3. Sartorius AG              
  4. MERCK KGaA           
  5. THERMO FISHER SCIENTIFIC INC.              
  6. Corning Incorporated             
  7. Cytiva           
  8. Lonza            
  9. Repligen        
  10. Catalent Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell therapy bioprocessing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global cell therapy bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00021550
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.

Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.

The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.

Pricing